Anis A. Khan

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

M. Pamela Griffin, Yuan Yuan, Therese Takas et al. · New England Journal of Medicine · 2020 · 699 citations · Full text

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

Qing Zhu, Jason S. McLellan, Nicole L. Kallewaard et al. · Science Translational Medicine · 2017 · 339 citations

Rsv Fusion, Respiratory Virus Immunity, Immunology +18

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants

Joseph B. Domachowske, Anis A. Khan, Mark T. Esser et al. · The Pediatric Infectious Disease Journal · 2018 · 222 citations · Full text

Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse

Hani Zaher, Anis A. Khan, Joe Palandra et al. · Molecular Pharmaceutics · 2006 · 159 citations

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults

M. Pamela Griffin, Anis A. Khan, Mark T. Esser et al. · Antimicrobial Agents and Chemotherapy · 2016 · 143 citations · Full text